NSUN4 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the NSUN4 enzyme. NSUN4 (NOP2/Sun RNA Methyltransferase Family Member 4) is a part of the RNA methyltransferase family, responsible for catalyzing methylation reactions on ribosomal RNA (rRNA). This enzyme primarily contributes to post-transcriptional modifications that are critical for the proper assembly and function of mitochondrial ribosomes. The role of NSUN4 is particularly notable in methylating cytosine residues, leading to the formation of 5-methylcytosine (m5C), which influences rRNA stability, processing, and the accurate translation of mitochondrial genes. Therefore, compounds that inhibit NSUN4 interfere with its enzymatic function, altering rRNA methylation and potentially disrupting mitochondrial ribosome biogenesis and protein synthesis.
Structurally, NSUN4 inhibitors are designed to interact with the active site of the enzyme, blocking its ability to bind to the rRNA substrate and transfer the methyl group from S-adenosylmethionine (SAM), the methyl donor. These inhibitors vary in chemical structure, often containing functional groups capable of binding to the catalytic pocket of NSUN4, thus preventing its methyltransferase activity. The development of these inhibitors can involve high-throughput screening of small molecule libraries or rational design based on the enzyme's three-dimensional structure. Some NSUN4 inhibitors possess scaffolds that mimic the enzyme's natural substrates, allowing them to competitively bind to the enzyme with high affinity. The specificity of NSUN4 inhibitors is important for their ability to selectively modulate mitochondrial function without affecting the broader cellular methylation processes conducted by other methyltransferases. Understanding the structure-activity relationship (SAR) of NSUN4 inhibitors helps guide the optimization of their binding properties and potency.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into genomic DNA, 5-Azacytidine could hypothetically lead to the demethylation of the NSUN4 gene promoter region, resulting in the downregulation of NSUN4 transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine, as a cytidine analog, may competitively inhibit DNA methyltransferases, potentially leading to reduced methylation and subsequent decrease in NSUN4 gene expression. | ||||||
Homocysteine | 6027-13-0 | sc-507315 | 250 mg | $195.00 | ||
This compound could inhibit NSUN4 by acting as a competitive inhibitor for methyltransferases, potentially leading to decreased methyl donor availability for the NSUN4 enzyme, thus reducing its expression. | ||||||
Hydralazine-15N4 Hydrochloride | 304-20-1 (unlabeled) | sc-490605 | 1 mg | $480.00 | ||
Hydralazine may induce hypomethylation of the NSUN4 gene promoter by inhibiting DNA methyltransferase enzymes, which could result in the downregulation of NSUN4 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and could conceivably block the binding of transcription factors to the NSUN4 promoter, which would decrease NSUN4 mRNA transcription. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is known to inhibit the transcription of various genes. It could specifically inhibit NSUN4 transcription by disrupting transcription factor activity or assembly of the transcriptional machinery. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine could interfere with the lysosomal degradation of NSUN4 mRNA, potentially leading to decreased levels of the mRNA and a subsequent reduction in NSUN4 protein synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates with DNA and may inhibit RNA polymerase movement, potentially leading to a blockade of NSUN4 mRNA synthesis and a decrease in protein expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, through its receptor-mediated transcriptional changes, could downregulate NSUN4 by altering the transcriptional activators or repressors that control the NSUN4 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is essential for protein synthesis. By inhibiting this pathway, rapamycin could decrease the translation of NSUN4 mRNA into protein. | ||||||